Skip to main content
. 2017 Feb 2;3(1):FSO165. doi: 10.4155/fsoa-2016-0071

Table 5. . Matrix effect of enalapril and enalaprilat calculated from six different source of human plasma.

Analytes Matrix effect (ME %)
Mean SD % CV
  SET 1 SET 2 SET 3 SET 4 SET 5 SET 6      
Enalapril
LQC (3 ng/ml)
95.8510
104.6398
106.0474
92.9591
109.0460
94.7069
100.5417
6.8260
6.7893
MQC (200 ng/ml)
113.3058
105.8869
90.9534
112.3145
91.5637
96.4744
101.7498
10.1036
9.9299
HQC (400 ng/ml)
103.3769
92.1597
99.1176
105.8241
94.9351
97.4031
98.8028
5.1258
5.1879
Enalaprilat
LQC (3 ng/ml)
106.9987
96.3672
110.2372
94.5207
95.3574
105.6815
101.5271
6.8825
6.7789
MQC (200 ng/ml)
94.9127
109.5726
101.5992
98.4407
105.2650
97.6180
101.2347
5.4176
5.3515
HQC (400 ng/ml) 95.3538 113.0894 91.0844 106.6942 90.7440 95.3352 98.7168 9.1079 9.2263

ME% expressed as the ratio of the mean peak area of an analyte spiked post extraction to the mean peak area of the same analyte standards multiplied by 100. A value of >100% indicates ionization enhancement, and a value of <100% indicates ionization suppression.

SET 1–6 represent the ME% from six different source of human plasma.

HQC: High quality control; LQC: Low quality control; ME: Matrix effect; MQC: Medium quality control.